Randomised clinical trial: the effectiveness of Gaviscon Advance vs non-alginate antacid in suppression of acid pocket and post-prandial reflux in obese individuals after late-night supper-Reference-Cited by-同舟云学术

Randomised clinical trial: the effectiveness of Gaviscon Advance vs non-alginate antacid in suppression of acid pocket and post-prandial reflux in obese individuals after late-night supper

Published:2020-04-28 Issue:11 Volume:51 Page:1014-1021
ISSN:0269-2813
Container-title:Alimentary Pharmacology & Therapeutics
language:en
Short-container-title:Aliment Pharmacol Ther

Author:

Deraman Mohd Adli¹,Abdul Hafidz Muhammad Ilham²,Lawenko Rona Marie³,Ma Zheng Feei¹⁴^ORCID,Wong Mung Seong¹,Coyle Cathal⁵^ORCID,Lee Yeong Yeh¹⁶⁷^ORCID

Affiliation:

1. School of Medical Sciences; Universiti Sains Malaysia; Kota Bahru Malaysia

2. Faculty of Medicine; Universiti Teknologi MARA; Sungai Buloh Malaysia

3. De La Salle Health Sciences Institute; Dasmarinas Philippines

4. Department of Health and Environmental Sciences; Xi'an Jiaotong-Liverpool University; Suzhou China

5. Reckitt Benckiser; Slough UK

6. Gut Research Group; Faculty of Medicine; Universiti Kebangsaan Malaysia; Kuala Lumpur Malaysia

7. St George and Sutherland Clinical School; University of New South Wales; Sydney NSW Australia

Funder

Reckitt Benckiser (M) Sdn. Bhd

Publisher

Wiley

Subject

Pharmacology (medical),Gastroenterology,Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/apt.15746/fullpdf

Reference26 articles.

1. Disruption of the gastroesophageal junction by central obesity and waist belt: role of raised intra-abdominal pressure;Lee;Dis Esophagus,2015

2. Current pharmacological management of gastroesophageal reflux disease;Wang;Gastroent Res Pract,2013

3. Waist belt and central obesity cause partial hiatus hernia and short-segment acid reflux in asymptomatic volunteers;Lee;Gut,2014

4. Central obesity in asymptomatic volunteers is associated with increased intrasphincteric acid reflux and lengthening of the cardiac mucosa;Robertson;Gastroenterology,2013

5. The burden of overweight and obesity in the Asia-Pacific region;Asia Pacific Cohort Studies Collaboration;Obes Rev,2007

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Experimental drugs for erosive esophagitis: what is in the clinical development pipeline?;Expert Opinion on Investigational Drugs;2024-08-30

2. Management advice for patients with reflux-like symptoms: an evidence-based consensus;European Journal of Gastroenterology & Hepatology;2024-01

3. S2k-Leitlinie Gastroösophageale Refluxkrankheit und eosinophile Ösophagitis der Deutschen Gesellschaft für Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten (DGVS) – März 2023 – AWMF-Registernummer: 021–013;Zeitschrift für Gastroenterologie;2023-07

4. Konservative Therapie der gastroösophagealen Refluxkrankheit;Gastroösophageale Refluxerkrankung;2023

5. The views of African and Middle Eastern Gastroenterologists on the management of mild-to-moderate, non-erosive gastro-esophageal reflux disease (GERD);Expert Review of Gastroenterology & Hepatology;2022-02-25